This site is intended for health professionals only

Editor’s pick

“No gain” from concurrent erlotinib in NSCLC
“No gain” from concurrent erlotinib in NSCLC
Barcode assistance of hospital dispensing potentially cost-effective
Barcode assistance of hospital dispensing potentially cost-effective
HRT linked to higher ovarian cancer risk
HRT linked to higher ovarian cancer risk
Rapid nanotechnology growth forecast over next five years
Rapid nanotechnology growth forecast over next five years
No adverse effect of rosiglitazone on cardiac function
No adverse effect of rosiglitazone on cardiac function
Eating less salt could prevent cardiovascular disease
Eating less salt could prevent cardiovascular disease
Amgen dismisses claims it is in trouble
Amgen dismisses claims it is in trouble
Aranesp linked to higher death rate in cancer trial
Aranesp linked to higher death rate in cancer trial
Genzyme and Cytochroma settle out of court
Genzyme and Cytochroma settle out of court
Anti-TNF efficacy in rheumatoid arthritis
Anti-TNF efficacy in rheumatoid arthritis
European biotech flourishes
European biotech flourishes
Positive results for Gleevec in GIST trial
Positive results for Gleevec in GIST trial
1 … 268 269 270 271 272 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x